Leadership Team

Patrick Hurban is Chief Scientific Officer and Vice President of Genomics. Prior to this he was responsible for global scientific oversight of genomic and molecular testing within IQVIA Laboratories, encompassing bioinformatics and laboratory methods, from identification and evaluation of new technology to development and validation of assays to support research and clinical programs. He has an extensive background in molecular genetics, including more than 25 years of experience in positions of increasing responsibility spanning laboratory operations, technology development and strategic marketing in organizations focused on research & development and clinical trials.

Following a Bachelor’s degree in Biology from the University of North Carolina at Chapel Hill, Pat earned a Ph.D. in Human Genetics from the University of Utah in Salt Lake City before serving as a Postdoctoral Research Fellow of the American Cancer Society in the Department of Developmental Biology at Stanford University.

John Cochran is Vice President, Chief Medical Officer, and Chief Pathologist. He is responsible for global medical oversight of all clinical testing where results drive patient selection and treatment in the context of clinical trials. In concert with the CSO, he identifies and validates new assays and technologies which will benefit patients in clinical trial lab testing. Dr. Cochran has an extensive background as a practicing pathologist for >20 years, having founded his own practice. Dr. Cochran was involved in a number of sentinel clinical trials that established PD-L1 as a biomarker for immunologic tumor therapy as well as for potential treatments of Metabolic Dysfunction-Associated Steatohepatitis (MASH).  He served as Clinical Director of The Joint Commission’s Laboratory Accreditation Program from 2014-2016. Dr. Cochran has performed numerous laboratory inspections on behalf of both The Joint Commission as well as the College of American Pathologists of which he is a Fellow.  

Dr. Cochran received his Bachelor of Science in Biology (Biochemistry) at Emory College of Emory University (Atlanta, GA). He continued at Emory University’s School of Medicine for his MD, followed by post-graduate residency training in Pathology and Laboratory Medicine at Emory University Affiliated Hospitals. He is Board-certified in Pathology and holds medical licenses in Georgia, Florida, New York, and California. 

Kevin Dooley is the Chief Human Resources Officer of IQVIA Laboratories , where he is responsible for ensuring that IQVIA Laboratories has the right people strategy in place that is in line with the company’s values and business strategy. Prior to joining IQVIA Laboratories, Kevin has held a variety of leadership positions at Deutsche Bank, and most recently led the Human Resources function for 3,000 people. Prior to Deutsche Bank, Kevin spent some time in the consumer products and manufacturing sectors with Colgate Palmolive and PepsiCo. Kevin has more than 20 years of experience in Human Resources, Communications, and Employer Branding and Marketing, from different industries. Having lived and worked in London, Hong Kong, Singapore, and various cities in the US, he brings a strong international perspective when it comes to leading and managing businesses.

Kevin earned a Bachelor of Science in Behavioral Sciences from the New York Institute of Technology and a Master of Arts in Industrial Organizational Psychology from Hofstra University.

Elaine Lowey is the Vice President and General Manager for Global Central Laboratories. In this role, she oversees operational delivery and financial performance, strategically networking, and ensuring exceptional customer delivery. Additionally, Elaine provides leadership and support to the central laboratories EMEA leadership team.

With a Bachelor of Science (Hons) in Immunology and Pharmacology from the University of Strathclyde, Elaine brings over 23 years of rich experience to her role. Her educational background is complemented by a certification from the Yale School of Management, reflecting her commitment to continuous learning and professional development.

Elaine's career is marked by her extensive global experience in nurturing customer-facing teams across diverse geographical locations. She has a proven track record of driving strategic initiatives and fostering collaboration within internal and external enterprise governance frameworks.

David is Vice President and General Manager of BioFortis, a IQVIA Laboratories Company, where he is responsible for managing the delivery of the digital technologies strategy, as well as the management of day-to-day operations and support. He is focused on ensuring that the full suite of digital technologies services and products is integrated into IQVIA Laboratories’ offerings, inclusive of its go-to-market strategy. Previously, David served as Chief Operating Officer of BioFortis. He has 20 years of management experience gained at several technology, financial services, and business services organizations.

David earned a B.B.A in Finance, and a J.D., both from George Washington University.

Simon Thornley is Vice President of quality and compliance, where he leads world-class quality and compliance systems within the new organization. With more than 20 years of quality assurance (QA) experience supporting pharmaceutical industry clients, Simon was previously the global director of QA and regulatory affairs for Quest Diagnostics clinical trials. This included managing a global program of quality and compliance audits across technical and non-technical business processes, hosting client and regulatory audits, managing client QA relationships, and supporting the business in meeting the industry's high expectations of quality.

Simon earned a Bachelor of Science from the Nottingham Trent University.

Dr. Wang is Vice President and Head of Innovation, where he develops, directs and implements the organization’s innovation. Previously, he was the CEO of BioFortis, the IQVIA Laboratories precision medicine and technology solutions company. For more than 20 years, Dr. Wang developed several software products with pharmaceutical customers, government agencies, and academia. He has deep knowledge in the rapidly evolving field of precision medicine and its associated biomarker-driven clinical trials, and strives to bring precision medicine technology solutions to researchers to help solve real-world health problems.